{
    "root": "349e2ce2-f399-926c-e063-6294a90a9185",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Indomethacin",
    "value": "20250508",
    "ingredients": [
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "POVIDONE",
            "code": "FZ989GH94E"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "POTASSIUM CATION",
            "code": "295O53K152"
        },
        {
            "name": "INDOMETHACIN",
            "code": "XXE1CET956"
        }
    ],
    "indications": "indomethacin extended-release capsules indicated : • moderate severe rheumatoid arthritis including acute flares chronic disease • moderate severe ankylosing spondylitis • moderate severe osteoarthritis • acute painful shoulder ( bursitis and/or tendinitis )",
    "contraindications": "• lowest effective shortest duration consistent individual patient treatment goals ( 2.1 ) • moderate severe rheumatoid arthritis including acute flares chronic disease ; moderate severe ankylosing spondylitis ; moderate severe osteoarthritis one indomethacin extended-release 75 mg capsule daily ( 2.2 ) • acute painful shoulder ( bursitis and/or tendinitis ) one indomethacin extended-release 75 mg capsule twice daily ( 2.3 )",
    "warningsAndPrecautions": "indomethacin extended-release capsules usp , 75 mg size ‘ 2 ’ , dark yellow cap clear transparent body hard gelatin capsules , containing cream spherical pellets imprinted ‘ h ’ cap ‘ 105 ’ body . supplied bottles 30 capsules ndc 31722-565-30 bottles 60 capsules ndc 31722-565-60 bottles 100 capsules ndc 31722-565-01 bottles 500 capsules ndc 31722-565-05 bottles 1000 capsules ndc 31722-565-10 storage store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] . protect moisture",
    "adverseReactions": "indomethacin extended-release capsules contraindicated following patients : • known hypersensitivity ( e.g . , anaphylactic serious skin ) indomethacin components product [ ( 5.7 , 5.9 ) ] • history asthma , urticaria , allergic-type taking aspirin nsaids . severe , sometimes fatal , anaphylactic nsaids reported patients [ ( 5.7 , 5.8 ) ] • setting coronary artery bypass graft ( cabg ) surgery [ ( 5.1 ) ]",
    "indications_original": "Indomethacin extended-release capsules are indicated for: \n    • Moderate to severe rheumatoid arthritis including acute flares of chronic disease \n    • Moderate to severe ankylosing spondylitis \n    • Moderate to severe osteoarthritis \n    • Acute painful shoulder (bursitis and/or tendinitis)",
    "contraindications_original": "• Use the lowest effective dosage for shortest duration consistent with individual patient treatment goals ( 2.1 ) • The dosage for moderate to severe rheumatoid arthritis including acute flares of chronic disease; moderate to severe ankylosing spondylitis; and moderate to severe osteoarthritis is one indomethacin extended-release 75 mg capsule daily ( 2.2 ) • The dosage for acute painful shoulder (bursitis and/or tendinitis) is one indomethacin extended-release 75 mg capsule once or twice daily ( 2.3 )",
    "warningsAndPrecautions_original": "Indomethacin extended-release capsules USP, 75 mg are size ‘2’, dark yellow cap and clear transparent body hard gelatin capsules, containing cream spherical pellets imprinted with ‘H’ on cap and ‘105’ on body. They are supplied as \n    Bottles of 30 capsules                 NDC 31722-565-30 \n    Bottles of 60 capsules                 NDC 31722-565-60 \n    Bottles of 100 capsules               NDC 31722-565-01 \n    Bottles of 500 capsules               NDC 31722-565-05 \n    Bottles of 1000 capsules             NDC 31722-565-10 \n  \n                     Storage\n                       Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from moisture",
    "adverseReactions_original": "Indomethacin extended-release capsules are contraindicated in the following patients: \n    • Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to indomethacin or any components of the drug product\n \n  [see\n  \n   Warnings and Precautions (5.7,\n  \n   5.9)]\n \n  \n                       • History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients\n \n  [see\n  \n   Warnings and Precautions (5.7,\n  \n   5.8)]\n \n  \n                       • In the setting of coronary artery bypass graft (CABG) surgery\n \n  [see\n  \n   Warnings and Precautions (5.1)]"
}